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Validation of transpulmonary 
thermodilution variables in hemodynamically 
stable patients with heart diseases
Matthias Peter Hilty1*, Daniel Peter Franzen1,2, Christophe Wyss3, Patric Biaggi3 and Marco Maggiorini1
Abstract 
Background: Transpulmonary thermodilution is recommended in the treatment of critically ill patients presenting 
with complex shock. However, so far it has not been validated in hemodynamically stable patients with heart disease.
Methods: We assessed the validity of cardiac output, global end-diastolic volume index (GEDVI), an established 
marker of preload thought to reflect the volume of all four heart chambers, global ejection fraction (GEF) and cardiac 
function index (CFI) as variables of cardiac function, and extravascular lung water index (EVLWI) as indicator of pulmo-
nary edema in 29 patients undergoing elective left and right heart catheterization including left ventricular angiog-
raphy with stable coronary heart disease and normal cardiac function (controls, n = 11), moderate-to-severe aortic 
valve stenosis (AS, n = 10), or dilated cardiomyopathy (DCM, n = 8).
Results: Cardiac output was similar in controls, AS, and DCM, with good correlation between transpulmonary 
thermodilution and pulmonary artery catheter using the Fick method (r = 0.69, p < 0.0001). Left ventricular end-dias-
tolic volume was normal in controls and AS, but significantly higher in DCM (104 ± 37 vs 135 ± 63 vs 234 ± 24 ml, 
p < 0.01). GEDVI did not differentiate between patients with normal and patients with enlarged left ventricular 
end-diastolic volume (848 ± 128 vs 882 ± 213 ml m−2, p = 0.60). No difference in GEF and CFI was found between 
patients with normal and patients with reduced left ventricular ejection fraction. Patients with AS but not DCM had 
higher EVLWI than controls (9 ± 2 vs 12 ± 4 vs 11 ± 3 ml kg−1, p = 0.04), while there was only a trend in pulmonary 
artery occlusion pressure (8 ± 3 vs 10 ± 5 vs 14 ± 7 mmHg, p = 0.05).
Conclusions: Cardiac output measurement by transpulmonary thermodilution is unaffected by differences in 
ventricular size and outflow obstruction. However, GEDVI did not identify markedly enlarged left ventricular end-
diastolic volumes, and neither GEF nor CFI reflected the increased heart chamber volumes and markedly impaired left 
ventricular function in patients with DCM. In contrast, EVLWI is probably a sensitive marker of subclinical pulmonary 
edema particularly in patients with elevated left-ventricular-filling pressure irrespective of differences in left ventricular 
function.
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Cardiac function index, Global ejection fraction, Cardiac disease, Aortic valve stenosis, Dilated cardiomyopathy, 
Angiography, Pulmonary artery catheter
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
Transpulmonary thermodilution is recommended in 
the management of critically ill patients presenting with 
complex shock [1, 2], enabling a global assessment of 
hemodynamic status. Besides measurement of cardiac 
output, it also provides the volumetric preload parameter 
global end-diastolic volume index (GEDVI), cardiac func-
tion parameters such as global ejection fraction (GEF) 
and cardiac function index (CFI), and the extravascular 
lung water index (EVLWI) as a marker of pulmonary 
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edema [3]. In the setting of the critically ill patient in the 
intensive care unit, GEDVI has been successfully estab-
lished as an independent marker of cardiac preload in 
perioperative patients [3] and patients in septic shock [4]. 
Monnet and co-workers have found that GEDVI tended 
to be higher in patients with acute heart failure com-
pared with ALI/ARDS patients [5]. Both GEF and CFI 
have been found to correlate to some extent with ejec-
tion fraction as determined by echocardiography in an 
experimental acute myocardial infarction model [6] and 
a mixed critically ill patient population [7]. Further, the 
ratio between EVLWI and GEDVI has been revealed to 
identify patients with cardiogenic pulmonary edema [5].
Based on these data, the use of transpulmonary ther-
modilution is generalized across a broad population of 
critically ill patients, even though the validity of param-
eters derived from transpulmonary thermodilution 
remains largely unknown in the setting of cardiac disease. 
Even though GEDVI is thought to reflect the volume 
of all four heart chambers [4, 8–10], its validity regard-
ing the distinction between patients with normal and 
enlarged left ventricles has never been tested. In addition, 
the validity of GEF and CFI has been tested in hemody-
namically unstable patients only, where specific interven-
tions were associated with changes in cardiac output or 
stroke volume [6, 7, 11]. Again, their validity in hemo-
dynamically stable patients with cardiac disease remains 
unknown.
In order to fill this important gap, the aim of the pre-
sent study was to assess the validity of transpulmonary 
thermodilution-derived flow and volumetric parameters 
in hemodynamically stable cardiac patients with sus-
pected but stable coronary heart disease (controls), aortic 
valve stenosis (AS), and dilated cardiomyopathy (DCM) 
during elective left and right heart catheterization includ-
ing left ventricular angiography. Our hypothesis was that 
(I) transpulmonary thermodilution measurement of 
blood flow is unaffected by differences in ventricular size 
and outflow obstruction, (II) GEDVI permits the distinc-
tion between patients with normal and enlarged left ven-
tricular volumes, (III) GEF and CFI are lower in patients 
with reduced left ventricular systolic function, and (IV) 
EVLWI is elevated in patients with left ventricular sys-
tolic and diastolic dysfunction.
Methods
All protocols and procedures conformed to the Decla-
ration of Helsinki and were approved by the local ethics 
committee (EK-1649). Informed consent for the study 
protocol and all procedures has been obtained from all 
patients prior to inclusion. The placement of a pulmo-
nary artery catheter in addition to left heart catheteriza-
tion has been declared as a study specific intervention in 
the control group and was clinically mandated in patients 
with AS and DCM.
Study population and design
Patients planned for elective coronary angiography at 
the University Hospital of Zurich were screened for eli-
gibility. Clinical examination, thoracic X-ray, serum cre-
atinine analysis, and, in female patients, a pregnancy 
test were performed. Patients with moderate-to-severe 
AS and patients with DCM, as determined by echocar-
diography results, were included (Fig.  1). Patients with 
suspected coronary artery disease in absence of valvular 
disease, with preserved left ventricular ejection fraction 
(LV-EF >40%) [12] and without severe diastolic dysfunc-
tion (E/e′ < 15) [13], were included in the control group. 
Exclusion criteria were catecholamine-dependent cardio-
genic shock, respiratory failure requiring the application 
of positive end expiratory pressure (due to pulmonary 
edema), atrial fibrillation, atrioventricular conduction 
abnormalities, slow ventricular tachycardia, kidney fail-
ure (glomerular filtration rate <60 ml min−1 [14]), preg-
nancy, and inability to give informed consent. Included 
patients underwent elective coronary angiography, dur-
ing which left ventricular angiography, right heart cath-
eterization, and transpulmonary thermodilution were 
additionally performed. None of our patients had indi-
rect clinical signs for an aneurysm of the aorta. Directly 
after angiography, a standardized echocardiography 
examination was performed. Assignment of patients to 
the control, AS, and DCM groups was reevaluated based 
on the echocardiography results obtained during this 
study. Echocardiography, left and right heart catheter, 
and transpulmonary thermodilution measurements were 
compared between the three included patient groups. 
In addition, patients were divided in two groups of nor-
mal or enlarged left ventricular size for comparison of 
left ventricular end-diastolic volume as determined by 
left ventricular angiography and GEDVI, as well as two 
groups of normal or reduced left ventricular function for 
comparison of left ventricular ejection fraction as deter-
mined by left ventricular angiography and GEF and CFI. 
A left ventricular end-diastolic volume as determined 
by left ventricular angiography of ≤106  ml in females 
and ≤150 ml in males and an ejection fraction as deter-
mined by left ventricular angiography of >53% in females 
and >51% in males, were considered normal, respectively 
[12].
Left heart catheterization
After puncture of the femoral artery, coronary angi-
ography was performed as clinically indicated and fol-
lowed by biplanar left ventricular angiography. Aortic 
pressure (Pa), as well as left ventricular end-diastolic 
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pressure (edPlv), and peak systolic pressure (sPlv) were 
recorded, and arterial blood was sampled. Left ventricu-
lar end-diastolic volume (LV-EDV) and end-systolic vol-
ume (LV-ESV) were determined from the left ventricular 
angiography using digital image analysis software (Xcel-
era R4.1 build 1173, Philips Medical Systems, Best, the 
Netherlands) by two independent, blinded examinators. 
The mean of both results is reported. Stroke volume and 
LV-EF were calculated from LV-EDV and LV-ESV.
Right heart catheterization
After puncture of the femoral vein, a 7F balloon-tipped 
pulmonary artery catheter (Edwards Lifesciences, Irvine, 
CA, USA) was floated into the pulmonary artery under 
constant radiologic and pressure wave monitoring for 
recording of pulmonary artery pressure (Ppa) and pul-
monary artery occlusion pressure (Ppao), as well as for 
mixed venous blood sampling. Then, the catheter was 
retracted through the right ventricle into the right atrium 
where right ventricular end-diastolic pressure (edPrv) 
and right atrial pressure (Pra) were measured. All pres-
sure measurements were recorded at end expiration, and 
Ppao and Pra were measured at the onset of the c wave 
that was identified through correlation with the elec-
trocardiogram on the time axis. Blood gas analysis on 
arterial and mixed venous blood samples for the meas-
urement of arterial and mixed venous hemoglobin oxy-
gen saturation as well as hemoglobin concentration was 
performed on site without delay (ABL800 Flex, Radi-
ometer, Copenhagen, Denmark). Cardiac output was 
determined using Fick’s equation using predicted oxygen 
consumption according to LaFarge and Miettinen [15]. 
N-terminal B-type natriuretic peptide was determined 
from a venous blood sample using an electrochemilu-
minescence immunoassay (Elecsys 2010 analyzer, Roche 
Diagnostics, Basel, Switzerland) [16].
Transpulmonary thermodilution measurements
After measurement of Pra, the tip of the Swan-Ganz 
catheter was carefully positioned at the intersection 
between the inferior vena cava and the right atrium 
using fluoroscopy. Transpulmonary thermodilution was 
then performed using a PiCCO thermodilution catheter 
inserted through the arterial access sheath and connected 
to a PiCCO2 monitor (Pulsion Medical Systems, Munich, 
Germany). Three boli of 20  ml of cold saline tempered 
to 5  °C were rapidly injected, and in case of an error of 
>10% in cardiac output between the three measure-
ments, another two measurements were taken. Measure-
ments resulting in a peak temperature difference during 
the thermodilution bolus of <0.15  °C were discarded. 
Data from the PiCCO2 monitor were recorded digitally 
through the system’s USB interface. Parameters directly 
derived from the thermodilution curve by the moni-
tor’s software included cardiac output (Q), intrathoracic 
thermal volume (ITTV), and pulmonary thermal volume 
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Fig. 1 Study design and measurement protocol. Patients planned for elective coronary angiography in a university hospital were included in the 
study based on the presence of moderate-to-severe aortic valve stenosis or dilated cardiomyopathy in echocardiography. A control group was 
formed consisting of patients devoid of valvular disease, severe diastolic dysfunction (E/e′ ratio > 15), and reduced LV-EF <40%. During the coronary 
angiography session, left and right heart catheterization, left ventricular angiography, and transpulmonary thermodilution were performed. AS 
aortic valve stenosis, DCM dilated cardiomyopathy, LV-EF left ventricular ejection fraction
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(PTV), as well as the estimation of intrathoracic blood 
volume (ITBV) and pulmonary blood volume (PBV). 
Parameters calculated therefrom included stroke volume 
(SV), global end-diastolic volume index (GEDVI = [ITTV 
– PTV]/predicted body surface area), global ejection 
fraction (GEF  =  SV/[GEDV/4]), cardiac function index 
(CFI = Q/GEDV × 103), extravascular lung water index 
(EVLWI  =  [ITTV  −  GEDV  ×  1.25]/predicted body 
weight), and pulmonary vascular permeability index 
(PVPI = EVLW/PBV). In addition, left ventricular stroke 
work index was calculated  using Ppao measured by the 
pulmonary artery catheter (LVSWI = SV/predicted body 
surface area  ×  [sPlv  −  Ppao]  ×  0.0136). ITTV, PTV, 
ITBV, and PBV, since they are not reproduced in the 
PiCCO2 monitor’s digital output, were reverse-calcu-
lated from GEDVI and EVLWI as saved by the monitor. 
The mean of the three-to-five transpulmonary thermodi-
lution measurements is reported for all parameters.
Echocardiography examination
Echocardiography examinations were performed tran-
sthoracically using a stationary device with tissue Doppler 
imaging capability (iE33 ultrasound system, Koninklijke 
Philips N.V., Amsterdam, the Netherlands). The left ven-
tricular end-diastolic and end-systolic volume and LV-EF 
were measured using the biplane disk summation tech-
nique [12], in addition to assessment of wall thickness 
and ventricular mass index. The ratio between mitral 
inflow velocity and lateral mitral annular velocity (E/e′) 
was assessed using pulsed wave and tissue Doppler imag-
ing in order to quantify left ventricular diastolic function. 
Moderate and severe diastolic dysfunction were consid-
ered present given an E/e′ ratio of 8–15 and >15, respec-
tively [13]. Interpretation of the E/e′ ratio was omitted 
in patients with moderate-to-severe mitral regurgitation 
[13]. Right ventricular fractional area change and tri-
cuspid annular plane systolic excursion were measured 
to assess right ventricular systolic function. Aortic valve 
area was estimated using the continuity equation [17]. 
Moderate and severe AS were considered present with 
an aortic valve area of 1.0–1.5 and <1.0 mm2, respectively 
[17]. DCM was defined as excentric ventricular hyper-
trophy with a relative wall thickness ≤0.42 cm and a left 
ventricular myocardial mass index of >95 and >115 g m−2 
in females and males, respectively [12, 18]. All measure-
ments were performed in triplicates and recorded digi-
tally for offline assessment which was performed after 
removal of subject identifiables. The means of the three 
respective measurements are reported.
Statistical analysis
Comparisons of measurements between the control, AS, 
and DCM groups were performed using independent 
measures one-way analysis of variance (ANOVA), with 
group membership as the main factor. Pairwise analy-
sis was performed using pairwise two-sample tests with 
Benjamini and Hochberg’s correction algorithm [19] 
applied. Comparisons of volumetric measurements 
between left ventricular angiography and transpulmo-
nary thermodilution were performed using linear corre-
lation employing Pearson’s product-moment correlation 
coefficient alongside Bland–Altman analysis [20] with 
percentage error analysis [21]. A two-sided p < 0.05 was 
considered statistically significant. For all statistical anal-
ysis, a fully scripted and reproducible data management 
pathway was created within the R environment for statis-
tical computing, version 3.2.2 [22]. Graphical output was 
generated using the R library ggplot2, version 2.0.0 [23]. 
Values are given as mean ± standard deviation (SD).
Results
Patient characteristics
Twenty-nine patients were included, 10 with AS, 8 with 
DCM, and 11 in the control group. Patients with AS were 
older than those with DCM and controls (Table  1). All 
patients had similar body surface area and hemoglobin 
concentration. Patients in the AS and DCM groups 
were fairly well compensated with a mean NYHA class 
between 2 and 3. Only one patient in the AS and DCM 
groups, respectively, demonstrated rales on clinical lung 
examination, and one patient in the DCM group had 
signs of redistribution on the thoracic X-ray film. Patients 
in the DCM group presented with a slightly higher lac-
tate and N-terminal B-type natriuretic peptide levels 
than patients with AS or controls. In all groups, mean 
lactate concentration was less than 2  mmol  l−1. Echo-
cardiography indicated severe AS in 4/10 (40%) patients 
in the AS group and moderate AS in the remaining six. 
Overall, the mean aortic valve area was 1.0 mm2, and the 
mean pressure gradient was 26  mmHg in the AS group 
(Table 1). An increasing left ventricular mass index was 
observed starting from the control group with progres-
sion to the AS and DCM groups, while the DCM group 
presented with enlarged LV-EDV. The latter patients 
presented with a decreased LV-EF, while all groups dem-
onstrated similar diastolic function as measured by E/e′, 
with a trend toward higher values in the AS group. Ppao 
was 14  mmHg in the DCM group, whereas it was 10 
and 8 mmHg in the AS group and controls, respectively 
(p  =  0.05). Three patients in the DCM group suffered 
from moderate-to-severe secondary mitral regurgita-
tion, as opposed to none in the AS and control groups. 
Patients in the DCM group also presented with only 
slightly increased right ventricular longitudinal diameter 
as compared to the AS and control groups, with similar 
right ventricular transversal diameters. Right ventricular 
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function and Pra were normal in all groups. No patients 
presented with moderate-to-severe tricuspid regurgita-
tion. Pulmonary vascular resistance was normal in all 
groups.
Cardiac output and contractility
As assessed by transpulmonary thermodilution, cardiac 
output and stroke volume were within normal range and 
similar between controls, AS and DCM groups (Table 2), 
despite a significantly lower LV-EF (32%) in the latter 
group as compared to LV-EF  >  55% in the AS and con-
trol groups (p < 0.001; Tables 1 and 2) as determined by 
left ventricular angiography as well as echocardiography. 
A good correlation between cardiac output measurements 
by transpulmonary thermodilution and pulmonary artery 
catheter via the Fick method was observed (r  =  0.69, 
p  <  0.0001). Bland–Altman analysis revealed a bias of 
0.9  l  min−1 with a precision 0.8  l  min−1 (level of agree-
ment −0.7 to 2.6  l min−1) and mean percentage error of 
33% (Fig.  2). No difference in GEF and CFI was found 
between the three groups (Table  2), as well as between 
patients with normal versus reduced LV-EF as determined 
by left ventricular angiography regardless of group alloca-
tion (Table 3; Fig. 3b). In addition, there was no linear rela-
tionship between LV-EF as measured by left ventricular 
angiography and GEF (r = 0.32, p = 0.09) or CFI (r = 0.27, 
p  =  0.15) as measured by transpulmonary thermodilu-
tion. In contrast, LVSWI was significantly lower in DCM 
patients when compared to the other two groups (Table 2).  
Cardiac volumes
Patients in the DCM group were well differentiated 
from the AS and control groups in left ventricular angi-
ography by their larger LV-EDV (p  <  0.001 in pairwise 
analysis for DCM versus AS and DCM versus controls). 
No difference was found in GEDVI between all three 
groups (Table  2), as well as between patients with nor-
mal versus enlarged left ventricular end-diastolic volume 
as determined by left ventricular angiography (Table  3; 
Fig.  3a). Similarly, neither the mean transit time or the 
exponential downslope time derived from the transpul-
monary thermodilution curves, nor the intrathoracic 
Table 1 Patient characteristics
Values are given as mean ± SD. Pairwise analysis is represented  bya,b where p < 0.05 versus the control and AS groups, respectively. (*)n = 5 for E/e′ ratio reported in 
the DCM group, since E/e′ ratio measurements were discarded in patients with moderate-to-severe mitral regurgitation
AS aortic valve stenosis, DCM dilated cardiomyopathy, BSA body surface area, NYHA New York Heart Association functional classification of heart failure, Hb 
hemoglobin
Control
n = 11
AS
n = 10
DCM
n = 8
p
Age [a] 62 ± 7 78 ± 11a 56 ± 14b <0.001
Sex (male) 9/11 7/10 7/8 0.64
BSA predicted  [m2] 1.80 ± 0.15 1.74 ± 0.16 1.82 ± 0.11 0.46
NYHA class [1] 1.5 ± 0.5 2.4 ± 0.7 2.0 ± 1.2 0.07
Hb [g l−1] 139 ± 18 133 ± 9 132 ± 15 0.51
Lactate [mmol l−1] 0.8 ± 0.3 0.5 ± 0.2 0.9 ± 0.3b 0.02
N-terminal B-type natriuretic peptide [ng l−1] 177 ± 216 882 ± 994 1423 ± 1132a 0.01
Echocardiography, left ventricle (LV)
 LV end-diastolic volume [ml] 98 ± 35 97 ± 21 181 ± 25ab <0.0001
 LV myocardial mass index [g m−2] 96 ± 16 116 ± 21a 145 ± 19ab <0.001
 LV ejection fraction [%] 64 ± 7 60 ± 13 32 ± 9ab <0.0001
 E/e′ ratio [1] 9.4 ± 3.3 12.0 ± 2.3 11.0 ± 3.4(*) 0.21
Echocardiography, right ventricle (RV)
 RV transversal diameter (D2) [mm] 27 ± 6 26 ± 5 29 ± 11 0.73
 RV longitudinal diameter (D3) [mm] 68 ± 5 66 ± 10 78 ± 12b 0.04
 Tricuspid annular plane systolic excursion [mm] 23 ± 4 23 ± 6 19 ± 5 0.23
 RV fractional area change [%] 47 ± 11 52 ± 12 50 ± 17 0.74
Echocardiography, aortic valve
 Aortic valve area  [mm2] 3.0 ± 1.5 1.0 ± 0.4a 2.5 ± 0.4b <0.0001
 Aortic valve peak instantaneous pressure gradient [mmHg] 3.8 ± 3.4 48.9 ± 26.2a 5.4 ± 2.2b <0.0001
 Aortic valve mean pressure gradient [mmHg] 2.3 ± 2.1 26.2 ± 17.8a 3.4 ± 1.2b <0.001
Echocardiography, mitral valve
 Secondary, moderate-to-severe mitral regurgitation 0/11 0/10 3/8 0.07
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or the pulmonary thermal volume differed between the 
three groups (Table 4). Further, no linear relationship was 
found between LV-EDV indexed for predicted body sur-
face area as measured by left ventricular angiography and 
GEDVI as measured by transpulmonary thermodilution 
(r = 0.002, p = 0.99).
Extravascular lung water
All ten of the patients in the AS group presented with 
normal LV-EF but moderate-to-severe diastolic dys-
function. In the DCM group, all patients presented with 
significantly depressed LV-EF, but only 6 of 8 (75%) with 
moderate-to-severe diastolic dysfunction. As selected 
by the inclusion criteria, in the control group none of 
the patients presented with severe diastolic dysfunction, 
but in 5/11 (45%) moderate diastolic dysfunction was 
present. Overall E/e′ ratio in the AS, DCM, and control 
groups was similar, with a trend toward higher mean 
E/e′ ratio in the AS group (Table 1). Ppao was highest in 
DCM (14 mmHg), but normal (≤10 mmHg) in the other 
two groups (p = 0.05, Table 2; Fig. 4). Patients with AS 
but not DCM had higher EVLWI than controls (p < 0.05 
in pairwise analysis for DCM vs. control, Fig. 4), a signal 
that remained undetected by raw thermodilution data 
(Table 4) before mathematical processing was applied in 
order to derive EVLWI, namely subtracting a multiple 
of the difference between ITTV and PTV from ITTV 
itself. Pulmonary vascular permeability index (PVPI) 
was found to be <3 in all groups. Ppao as measured by 
pulmonary artery catheter correlated well to edPlv as 
measured by left ventricular angiography (r  =  0.63, 
p  <  0.001; bias −8  mmHg, precision 5  mmHg, level of 
agreement −19 to 3  mmHg), while no linear relation-
ship was found between EVLWI and Ppao (r  =  0.10, 
p = 0.60).
Discussion
The present study, using state-of-the art invasive ref-
erence hemodynamic measurements, demonstrates 
that (I) transpulmonary thermodilution measurement 
of blood flow is unaffected by differences in ventricu-
lar size and outflow obstruction. However, (II) GEDVI 
Table 2 Hemodynamic status and transpulmonary thermodilution measurements in patients with aortic valve stenosis, 
dilated cardiomyopathy, and controls
Values are given as mean ± SD. Pairwise analysis is represented  bya,b where p < 0.05 versus the control and AS groups, respectively
AS aortic valve stenosis, DCM dilated cardiomyopathy
Control
n = 11
AS
n = 10
DCM
n = 8
p
Heart rate  [min−1] 70 ± 9 67 ± 6 71 ± 13 0.62
Cardiac output (pulmonary artery catheter) [l min−1] 5.0 ± 0.9 4.3 ± 1.4 4.0 ± 0.9 0.13
Left ventricular peak systolic pressure (sPlv) [mmHg] 145 ± 29 160 ± 34 126 ± 19 0.06
Mean aortic pressure (mPa) [mmHg] 103 ± 20 91 ± 14 90 ± 12 0.15
Left ventricular stroke work index (LVSWI) [g m s−2 m−2] 82 ± 12 100 ± 28 63 ± 23b <0.01
Transaortic peak-to-peak pressure gradient (sPlv–sPa) [mmHg] 1 ± 8 19 ± 14a 1 ± 4b <0.001
Right ventricular end-diastolic pressure (edPrv) [mmHg] 6 ± 4 6 ± 6 9 ± 6 0.27
Right atrial pressure (Pra) [mmHg] 4 ± 3 4 ± 2 7 ± 5 0.14
Mean pulmonary artery pressure (mPpa) [mmHg] 16 ± 6 16 ± 7 24 ± 11 0.08
Pulmonary artery occlusion pressure (Ppao) [mmHg] 8 ± 3 10 ± 5 14 ± 7a 0.05
Transpulmonary pressure gradient (mPpa–Ppao) [mmHg] 8 ± 4 6 ± 3 9 ± 6 0.38
Pulmonary vascular resistance [dyn s cm−5] 108 ± 55 93 ± 50 173 ± 174 0.23
Biplanar left ventricular angiography
 Stroke volume [ml] 64 ± 26 77 ± 20 76 ± 32 0.46
 Left ventricular end-diastolic volume [ml] 104 ± 37 135 ± 63 234 ± 24ab <0.0001
 Left ventricular ejection fraction [%] 62 ± 11 63 ± 16 32 ± 12ab <0.0001
Transpulmonary thermodilution (PiCCO2)
 Cardiac output [l min−1] 5.6 ± 0.9 5.5 ± 0.7 5.0 ± 1.0 0.35
 Stroke volume [ml] 81 ± 15 84 ± 15 75 ± 25 0.57
 Global end-diastolic volume index (GEDVI) [ml m− 2] 823 ± 106 909 ± 170 870 ± 252 0.54
 Global ejection fraction (GEF) [%] 22 ± 4 22 ± 4 20 ± 7 0.54
 Cardiac function index (CFI)  [min−1] 3.9 ± 0.8 3.6 ± 0.7 3.3 ± 0.8 0.32
 Extravascular lung water index (EVLWI) [ml kg−1] 9 ± 2 12 ± 4a 11 ± 3 0.04
 Pulmonary vascular permeability index (PVPI) [1] 2 ± 0 2 ± 0 2 ± 1 0.12
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as measured by transpulmonary thermodilution does 
not differentiate between patients with a normal-sized 
left ventricle and those with a left ventricle enlarged 
by DCM. This finding may not contradict GEDVI’s 
role as a preload indicator, but it might require a revi-
sion of its understanding as the volume of the four 
heart chambers. Furthermore, in our hemodynamically 
stable patients, (III) both transpulmonary thermodi-
lution-derived cardiac function parameters, GEF and 
CFI, failed to detect impaired LV-EF in DCM patients. 
In addition, we found that (IV) EVLWI is a sensi-
tive marker for the detection of subclinical pulmonary 
edema in patients with impaired diastolic and systolic 
cardiac function.
3
4
5
6
7
3 4 5 6 7
Cardiac output (pulmonary artery catheter) [l/min]
Ca
rd
ia
c 
ou
tp
ut
 (tr
an
sp
ulm
on
ary
 
th
er
m
o
di
lu
tio
n) 
[l/m
in]
−2
−1
0
1
2
3 4 5 6
Mean
D
iff
e
re
n
ce Control
AS
DCM
Fig. 2 Good correlation between cardiac output measurements by transpulmonary thermodilution and pulmonary artery catheter was observed 
[r = 0.69, p < 0.0001, bias 0.9 l min−1 (extended black line in the Bland-Altman plot), precision 0.8 l min−1, level of agreement −0.7 to 2.6 l min−1 
(dashed black line)]. The shaded area in the linear correlation plot denotes the fitted linear model’s 95% confidence interval. AS aortic valve stenosis, 
DCM dilated cardiomyopathy
Table 3 Comparison of volumetric parameters and measures of contractility as determined by left ventricular angiogra-
phy and transpulmonary thermodilution
Values are given as mean ± SD
Normal left ventricular  
end-diastolic volume
n = 14
Enlarged left ventricular  
end-diastolic volume
n = 15
p
Left ventricular end-diastolic volume [ml]  
(left ventricular angiography)
94 ± 28 203 ± 52 <0.0001
Global end-diastolic volume index (GEDVI) [ml m−2] 848 ± 128 882 ± 213 0.60
Normal left ventricular  
ejection fraction
n = 18
Reduced left ventricular  
ejection fraction
n = 11
Left ventricular ejection fraction [%]  
(left ventricular angiography)
67 ± 7 33 ± 13 <0.0001
Global ejection fraction (GEF) [%] 22 ± 4 21 ± 6 0.66
Cardiac function index (CFI)  [min−1] 3.7 ± 0.7 3.5 ± 0.9 0.61
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Cardiac output
Blood flow measurements by thermodilution are a spe-
cialized case of the indicator dilution principle based on 
a slightly modified Stewart–Hamilton formula [24]. The 
thermodilution technique has been successfully applied 
to measure regional blood flow in single blood vessel [25] 
as well as across a pulmonary artery catheter in order to 
assess global cardiac output [26]. Obviating the need for 
pulmonary artery catheterization by injection of a bolus 
of cold saline into the superior or inferior vena cava that 
is transported with the blood flow and detected by a ther-
mistor inserted into the femoral artery, transpulmonary 
thermodilution has been proven to match thermodilu-
tion measurement of blood flow across the right ventri-
cle using a pulmonary artery catheter in a perioperative 
setting [27, 28], in patients with heart failure primarily 
due to coronary heart disease [11] and in patients with 
severe mitral regurgitation undergoing valve repair [29]. 
The measurement of cardiac output has further been val-
idated against echocardiography in patients with severe 
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Fig. 3 Comparison of volumetric parameters and measures of contractility as determined by left ventricular angiography and transpulmonary ther-
modilution. Patients with normal versus enlarged left ventricular end-diastolic volume presented with similar values of GEDVI (a). Similarly, GEF did 
not differentiate patients with normal versus reduced left ventricular ejection fraction (b). Vertical dashed lines represent cutoff values for the normal 
range of left ventricular end-diastolic volume (a) and left ventricular ejection fraction (b) in females and males, respectively. Horizontal dashed lines 
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Table 4 Transpulmonary thermodilution mathematical model parameters
Values are given as mean ± SD
AS aortic valve stenosis, DCM dilated cardiomyopathy
Control
n = 11
AS
n = 10
DCM
n = 8
p
Mean transit time (MTt) [s] 442.9 ± 91.0 497.9 ± 88.7 570.8 ± 199.2 0.12
Exponential downslope time (DSt) [s] 173.1 ± 41.1 211.2 ± 47.2 246.0 ± 107.0 0.08
Thermal indicator volumetric parameters
 Intrathoracic thermovolume (ITTV) [ml] 2439 ± 470 2759 ± 662 2744 ± 754 0.43
 Pulmonary thermovolume (PTV) [ml] 956 ± 230 1176 ± 355 1159 ± 320 0.20
Estimated dye indicator volumetric parameters
 Intrathoracic blood volume (ITBV) [ml] 1854 ± 327 1979 ± 441 1982 ± 594 0.77
 Pulmonary blood volume (PBV) [ml] 371 ± 65 396 ± 88 396 ± 119 0.77
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AS [30]. Our study confirms these findings and further-
more expands the results to patients with DCM, present-
ing with severely enlarged left ventricular dimensions 
and moderately to severely impaired LV-EF, in a com-
parison with pulmonary artery catheter measurements. 
The finding allows the conclusion that turbulences in 
regional blood flow as they can be induced by obstruc-
tion at a stenosed aortic valve as well as by the presence 
of an enlarged left ventricle in the indicator’s path, do not 
influence the result of the Stewart–Hamilton equation to 
a clinically relevant extent. Therefore, measurement of 
cardiac output in this setting is reliable.
Global end-diastolic volume index
In analogy to flow measurements by transpulmonary 
indicator dilution, volumetric measurements have been 
developed using dye dilution. Some of these findings 
have later been translated to the use of a thermal indica-
tor. Early findings suggest that the volume in-between the 
injection and detection sites minus the largest volume 
chamber in the series may describe the combined volume 
of all four heart chambers [31, 32], temporally averaged 
over the measurement cycle of the indicator’s first pass. 
This new entity has been termed global end-diastolic 
volume. GEDVI is defined as the difference between the 
ITTV and the PTV, divided by the predicted body sur-
face area [3]. ITTV represents the distribution volume 
of the thermal indicator as determined by the product 
of cardiac output and the mean transit time (MTt) of the 
indicator bolus [32], and PTV is the product of cardiac 
output and the reciprocal of the elimination constant of 
the first-order elimination (exponential downslope time, 
DSt) of the indicator during its first pass through the 
measurement site (before recirculation occurs). It reflects 
the largest volume chamber in series between the site of 
injection and the tip of the femoral catheter [31]. Nota-
bly, the interconnection between DSt and volume cham-
bers serially passed by an indicator has been discovered 
and validated by Newman and co-workers in an in vitro 
model circulation rather than the human heart. Derived 
parameters such as GEDVI ultimately reflect the dissipa-
tion of an indicator through the volume chambers of the 
thoracic cavity. Even though GEDVI is thought to reflect 
the volume of all four heart chambers [31, 32], what it 
represents in a physiological context is less clear. Never-
theless, in the setting of a hemodynamically unstable crit-
ically ill or perioperative patient, GEDVI has been found 
to be an independent predictor of cardiac preload [3, 4]. 
GEDVI has previously been found to correlate to LV-
EDV as measured by echocardiography in a population 
of patients undergoing elective coronary artery bypass 
surgery [9, 33], with ventricular function and volumes 
close to normal. GEDVI’s relatively high inter-individual 
variability has been partially attributed to age and gender 
Fig. 4 Comparison of extravascular lung water index (EVLWI) as measured by transpulmonary thermodilution and pulmonary artery occlusion pres-
sure (Ppao). In patients with aortic valve stenosis and dilated cardiomyopathy a trend toward increased EVLWI and Ppao was detected, respectively, 
that may be related to subclinical pulmonary edema. ANOVA p = 0.04 for EVLWI, (*) denotes a significant difference versus the control group in 
pairwise analysis (p < 0.05). AS aortic valve stenosis, DCM dilated cardiomyopathy, ANOVA one-way analysis of variance
Page 10 of 13Hilty et al. Ann. Intensive Care  (2017) 7:86 
differences [34]. The present study for the first time adds 
to this understanding that no such association seems to 
exist in a patient population selected for large differences 
in left ventricular end-diastolic volume, by demonstrat-
ing that neither the direct properties of the transpulmo-
nary thermodilution curve such as MTt and DSt, nor the 
derived parameters, ITTV, PTV, and GEDVI, contain a 
signal that differentiates between patients with normal 
versus enlarged LV-EDV. This holds true even though 
the patients presenting with enlarged LV-EDV also had 
slightly enlarged right ventricles. Confounding factors 
were minimal, since all patients included in the present 
study had normal right ventricular and tricuspid valve 
function, the catheter tip was accurately placed at the 
entry of the right atrium by fluoroscopy and the pres-
ence of aortic aneurysms had been excluded using angi-
ography. In addition to these factors, due to the nature of 
transpulmonary thermodilution, GEDVI is averaged over 
the complete cardiac cycle and the term “end-diastolic” 
seems to be an oversimplification first appearing in the 
work by Goedje and co-workers [3]. Our findings may 
thus change our perception of GEDVI in a physiological 
context. GEDVI should be understood as a parameter 
resulting from the suppression of the signal of pulmo-
nary blood volume and extravascular lung water from the 
transpulmonary thermodilution curve, without differen-
tiating between the change in volume that occurs during 
the cardiac cycle. What remains is information about car-
diac preload, but not effective left ventricular end-dias-
tolic volume. The use of ITBV as the indicator of preload 
would avoid misunderstanding in the future.
Cardiac function
The CFI has been conceived as a parameter reflecting car-
diac performance independently of changes in intratho-
racic pressure, myocardial compliance, and vascular tone 
[35]. GEF is another cardiac functional parameter which 
is independent of heart rate. In analogy to the ventricular 
ejection fraction as measured by left ventricular angiog-
raphy or echocardiography, GEF is defined as the quo-
tient between the stroke volume and global end-diastolic 
volume divided by the number of the cardiac cavities (4). 
In pigs, good correlations were demonstrated between 
both CFI and GEF and left ventricular dP/dt [35, 36] and 
ejection fraction as determined by echocardiography in 
acute myocardial infarction [4]. Similar correlations were 
found in a mixed critically ill patient population between 
LV-EF as determined by echocardiography and both CFI 
and GEF [7, 8]. In all these studies, changes in CFI and/
or GEF were associated with changes in cardiac out-
put. In patients with septic shock, Jabot and co-workers 
found that GEF and CFI reflect the application of posi-
tive inotropy but not a volume challenge [37]. Ritter and 
co-workers, comparing patients with septic shock and 
acute heart failure, found CFI and GEF to be significantly 
lower in acute heart failure patients [11]. In this study, 
cardiac output was 4.6 l min−1 in septic and 2.7 l min−1 
in acute heart failure patients, whereas GEDVI was not 
different between groups (907 ml in sepsis and 995 ml in 
acute heart failure). In contrast, in our hemodynamically 
stable patients with no significant differences in cardiac 
output, stroke volume, and GEDVI, CFI and GEF did not 
reveal markedly depressed LV-EF of the DCM patients. 
However, calculating LVSWI—which takes into account 
besides stroke volume also the difference between mean 
Pa and Ppao—significant differences were found between 
the DCM group and the other two. Thus, our data sug-
gest that CFI and GEF values are surrogate markers of 
global cardiac function but not LV-EF, hence cardiac con-
tractility. In euvolemic hemodynamically stable patients 
monitored with a pulmonary artery catheter, calculation 
of LVSWI may be more suitable for the assessment of 
cardiac power, as Ppao values reflect myocardial systolic 
and diastolic function.
Extravascular lung water
Due to thermodynamic as well as hemodynamic interac-
tions within the pulmonary capillary network, the signal 
derived from transpulmonary thermodilution also con-
tains information about extravascular lung water that can 
be extracted by referencing it with a concomitantly per-
formed inert dye dilution [38]. EVLWI is thus defined as 
the difference between ITBV and ITTV divided by pre-
dicted body weight. ITBV is determined by dye dilution 
analogous to how ITTV is determined by thermodilu-
tion. Based on a largely linear relationship between global 
end-diastolic volume as determined by single-indicator 
transpulmonary thermodilution and ITBV as deter-
mined by single-indicator transpulmonary dye dilution as 
described in human studies [8, 39], ITBV is approximated 
by the PiCCO2 monitor by extrapolating global end-
diastolic volume using a constant factor of 1.25. EVLWI 
calculated in this way is thought to reflect the extravas-
cular water content of the lung within the same physi-
ological analogy that connects GEDVI with the volume 
of all four heart chambers. It has been demonstrated to 
reliably detect the presence of pulmonary edema [40] and 
through division by PBV, yielding PVPI, enable the differ-
entiation of its etiology [5]. It has also been suggested as 
a predictor for ICU mortality in a mixed ICU population 
[41]. Our study revealed an increased EVLWI in patients 
with moderate-to-severe AS and to a lesser extent in 
DCM. These results are consistent with previous obser-
vations showing that EVLWI may be elevated in hemody-
namically stable patients suffering from heart failure with 
reduced LV-EF (≤40%) as compared to healthy controls 
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[42]. In our study population, AS patients presented with 
preserved LV-EF and overall only moderate-to-severe AS 
and are thus expected to tolerate higher physical perfor-
mance levels as compared to the DCM patients. The find-
ing that EVLWI values were highest in AS patients could 
hence be explained by a very high Ppao during physical 
activity, leading to exercise induced subclinical pulmo-
nary edema. Since interstitial lung water may take one 
or more days to clear, while Ppao has already returned to 
baseline [43], EVLWI could indeed be an earlier indica-
tor of continually or intermittently elevated pulmonary 
capillary pressure due to compromised systolic and/
or diastolic cardiac function. This argument is further 
supported by our finding of elevated N-terminal B-type 
natriuretic peptide levels in patients with DCM with a 
trend toward higher values in the AS group, while clini-
cal and radiological signs of pulmonary edema or pleural 
effusion were absent in all groups. Additionally, the lack 
of correlation between Ppao and EVLWI in our study 
adds to previous observations in mixed patient popula-
tions [11, 43]. In our study, Ppao measurements repre-
sent a single observation in time while patients were lying 
supine and at rest.
Limitations
The present study was designed to compare transpul-
monary thermodilution measurements to left ventricu-
lar angiography and pulmonary artery catheterization in 
hemodynamically stable patients with cardiac disease. Our 
data only encompass one point in time, and the examina-
tions were not repeated during the course of treatment. 
Thus, no conclusions can be made regarding the dynamic 
response of the examined parameters to interventions. 
Additionally, even though left ventricular angiography is 
the accepted gold standard used to determine ventricular 
end-systolic and end-diastolic volumes, there are several 
technical limitations. A similar disk summation algorithm 
[12] is applied to the biplanar image of the ventricle as is 
commonly employed in echocardiography, but signal qual-
ity achieved by angiography is enhanced as compared to 
echocardiography due to increased spatial resolution and 
the possibility to analyze both perpendicular planes within 
the same heartbeat. Still, some error remains through the 
reliance on a biplanar instead of a three-dimensional cap-
ture. While the close correlation of the values to meas-
urements by echocardiography supports the validity of 
the data assessed in this study, it is not possible to derive 
information about the magnitude of this error, although 
it is expected to be small [12]. Further, while in the pre-
sent study, measurement of stroke volume by thermodi-
lution has been found to be accurate as compared to left 
ventricular angiography in obstructive and dilated heart 
disease, a conclusion cannot be reached regarding valve 
regurgitation based on the data presented. In the case of 
valve regurgitation, oscillating blood volume violates addi-
tional prerequisites for the Stewart–Hamilton formula as 
compared to obstructive and dilated heart disease. In the 
present study, the subgroup of patients exhibiting mod-
erate-to-severe mitral regurgitation is not large enough 
to derive a conclusion. Further studies are warranted to 
answer this question.
Conclusions
Cardiac output measurement by transpulmonary ther-
modilution is unaffected by outflow obstruction in aor-
tic valve stenosis and large differences in left ventricular 
end-diastolic volume as present in dilated cardiomyopa-
thy. However, in our study, GEDVI did not identify mark-
edly enlarged left ventricular end-diastolic volumes in 
patients with dilated cardiomyopathy. In addition, neither 
GEF nor CFI reflected markedly reduced left ventricular 
ejection fraction in the same patient population. Thus, in 
hemodynamically stable cardiac patients, transpulmo-
nary thermodilution has clear limitations and needs to be 
interpreted with caution. In contrast, EVLWI is probably 
a sensitive marker of subclinical pulmonary edema, par-
ticularly in patients with aortic valve stenosis presenting 
with elevated left ventricular filling pressure, irrespective 
of differences in left ventricular function.
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